Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jan-Mar;19(1):4-10.

Nesfatin-1 and its effects on different systems

Affiliations
Review

Nesfatin-1 and its effects on different systems

C Ayada et al. Hippokratia. 2015 Jan-Mar.

Abstract

Nesfatin-1 is a peptide secreted by peripheral tissues, central and peripheral nervous system. It is involved in the regulation of energy homeostasis related with food regulation and water intake. Nesfatin-1 can pass through the blood-brain barrier in both directions. It suppresses feeding independently from the leptin pathway and increases insulin secretion from pancreatic beta islet cells. That is why nesfatin-1 has drawn attention as a new therapeutic agent, especially for the treatment of obesity and diabetes mellitus. Its effects on nutrition have been studied in more detail in literature. On the other hand, its effects on other physiological parameters and mechanisms of action still need to be clarified. Synthesizing the research on nesfatin-1 can help us better understand this field. Hippokratia 2015, 19 (1): 4-10.

Keywords: Human nesfatin-1 protein; L-type calcium channels; anti-obesity agents; appetite depressants; human nucleobinding 2 protein; nerve tissue proteins.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Schematic drawing demonstrating the secretion fields of nesfatin-1. CNS: central nervous system.
Figure 2
Figure 2. Schematic drawing demonstrating the peripheral effect of nesfatin-1 on vessels. SNP: sodium nitroprusside, NO: nitric oxide, CaM: calmodulin, eNOS: endothelial nitric oxide synthase, cGMP: cyclic guanosine monophosphate, GTP: guanozin trifosfat, VD: vasodilatation.
Figure 3
Figure 3. Major clinical applications of nesfatin-1. GABA: gamma aminobutyric acid.

References

    1. Oh-I S, Shimizu H. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443:709–712. - PubMed
    1. Cowley MA, Grove KL. To be or NUCB2, is nesfatin the answer? Cell Metab. 2006;4:421–422. - PubMed
    1. Stengel A, Tach Y. Nesfatin-1 role as possible new potent regulator of food intake. Regul Pept. 2010;163:18–23. - PMC - PubMed
    1. Foo K, Brismar H, Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience. 2008;156:563–579. - PubMed
    1. Pan W, Hsuchou H, Kastin AJ. Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides. 2007;28:2223–2228. - PubMed

LinkOut - more resources